Slate Path Capital LP

Holdings History for Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)

Symbol: CUE on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value per share
Latest Disclosed Shares Owned: 918,836 shares
Security Ownership %: 1.4%

Shares, Excluding Options vs Price

Value, Excluding Options

Slate Path Capital LP ownership in Cue Biopharma, Inc. Common Stock, $0.001 par value per share (CUE)

14 Feb 2025 - Slate Path Capital LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 918,836 shares of Cue Biopharma, Inc. Common Stock, $0.001 par value per share (CUE). This represents 1.4% ownership of the company. This is the first filing by Slate Path Capital LP disclosing ownership of Cue Biopharma, Inc. Common Stock, $0.001 par value per share (CUE).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Slate Path Capital LP	1.4%		$790,199	918,836			$0.86	13G/A	31 Dec 2024	14 Feb 2025, 17:00

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2024		-0.03%	$0	0	-2,402,455	-100%	$0.31	Q4 2024
30 Sep 2024	0.03%	0%	$1,819,139	2,402,455	0		$0.76	Q3 2024
30 Jun 2024	0.06%	0%	$2,979,044	2,402,455	0		$1.24	Q2 2024
31 Mar 2024	0.09%	0%	$4,540,640	2,402,455	0		$1.89	Q1 2024
31 Dec 2023	0.14%	0%	$6,342,481	2,402,455	0		$2.64	Q4 2023
30 Sep 2023	0.15%	0%	$5,525,647	2,402,455	0		$2.30	Q3 2023
30 Jun 2023	0.32%	0%	$8,768,961	2,402,455	0		$3.65	Q2 2023
31 Mar 2023	0.4%	0%	$8,576,764	2,402,455	0		$3.57	Q1 2023
31 Dec 2022	0.37%	+0.14%	$6,846,997	2,402,455	+918,836	+62%	$2.85	Q4 2022
30 Sep 2022	0.22%	0%	$3,308,000	1,483,619	0		$2.23	Q3 2022
30 Jun 2022	0.23%	0%	$3,694,000	1,483,619	0		$2.49	Q2 2022
31 Mar 2022	0.37%	0%	$7,240,000	1,483,619	0		$4.88	Q1 2022
31 Dec 2021	0.88%	0%	$16,780,000	1,483,619	0		$11.31	Q4 2021
30 Sep 2021	0.99%	0%	$21,616,000	1,483,619	0		$14.57	Q3 2021
30 Jun 2021	0.97%	0%	$17,284,000	1,483,619	0		$11.65	Q2 2021
31 Mar 2021	1.2%	0%	$18,100,000	1,483,619	0		$12.20	Q1 2021
31 Dec 2020	1%	0%	$18,560,000	1,483,619	0		$12.51	Q4 2020
30 Sep 2020	1.3%	+0.53%	$22,328,000	1,483,619	+612,925	+70%	$15.05	Q3 2020
30 Jun 2020	1.3%	0%	$21,341,000	870,694	0		$24.51	Q2 2020
31 Mar 2020	0.96%	-0.02%	$12,355,000	870,694	-19,306	-2.2%	$14.19	Q1 2020
31 Dec 2019	0.77%	0%	$14,129,000	890,000	0		$15.88	Q4 2019
30 Sep 2019	0.5%	+0.5%	$7,503,000	890,000	+890,000	NEW	$8.43	Q3 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.